Follow-up care and treatment of patients diagnosed with urinary bladder cancer. Cancer
Conditions
Interventions
This interventional study includes patients with non-muscle invasive bladder cancer, stratified as pT1. The patients will undergo a standard second re-endoresection of the urinary bladder tumor. Befor
Sponsors
University Hospital Brno
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with diagnosed urinary bladder cancer stratified as pT1, who have to undergo re-endoresection of the urinary bladder tumor.
Exclusion criteria
Exclusion criteria: First histological examination without detection of muscle tissue (pTX), incomplete first resections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malign and benign lesions during re-endoresection of urinary bladder tumor will be measured using laser confocal endomicroscopy at one time point | — |
Secondary
| Measure | Time frame |
|---|---|
| Confirmation between benign and malignant lesions will be undertaken after the examination by laser confocal endomicroscopy, using histopathological examination at one time point | — |
Countries
Czech Republic
Contacts
Public ContactMária Moravcíková
Outcome results
None listed